2014 ASPEN Clinical Guidelines: Support of Pediatric Patients with Intestinal Failure at Risk of Parenteral Nutrition - Associated Liver Disease JPEN 2014 Vol. 38, Issue 5, pp. 538–557
Its primarygoal is to provide up-to-date evidence for health professionals working with infants, children and adolescents receiving parenteral nutri-tion (PN). It is based on literature collected in a systematic way and on expert opinion.
On this page, you will find the links to the full published papers used in the each of the Guideline Tools and Advice Guides. Please note that these guidelines have been optimised for viewing on a desktop device.
ASPEN provides clinical guidance documents* to assist our members in providing safe nutrition care to patients. These documents are developed by content experts and approved by the ASPEN Board of Directors.
In considering the maximal target dose, we recommend providing parenteral AA at a minimum of 3 g/kg/day and not exceeding 3.5 g/kg/day. This guidance accounts for growth outcomes as well as neurodevelopmental outcomes associated with AA dose as addressed
This document provides guidelines for nutrition support in critically ill pediatric patients from the Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition.
